Treatment of HCC cells with histone deacetylase (HDACs) inhibitor or knockdown of HDAC1 and/or HDAC2 restored FBP1 expression and inhibited HCC cells growth. The gene discussed is FBP1; the disease is hepatocellular carcinoma.